Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1855]

Anastrazole offers higher breast cancer-free survival rates than tamoxifen...

Prof Richard Margolese - The Jewish General Hospital, McGill University...

Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS ( Prof Richard Margolese - The Jewish General Hospital, McGill University, Montreal, Canada )

Extensive lymph node surgery may not be necessary for some patients with...

Prof Claus Garbe - University of Tübingen, Tübingen, Germany.

Extensive lymph node surgery may not be necessary for some patients with melanoma ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany. )

First effective adjuvant chemotherapy for high-risk, localised prostate cancer

Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA.

First effective adjuvant chemotherapy for high-risk, localised prostate cancer ( Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA. )

Obinutuzumab doubles remission duration in patients with relapsed, indolent non...

Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada

Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma ( Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada )

First-in-class targeted drug daratumumab shows promise in heavily treatment...

Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA

First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma ( Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA )

Pembrolizumab for head and neck cancer

Dr Tanguy Seiwert - University of Chicago, Chicago, USA

Pembrolizumab for head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )

Nivolumab extends survival for patients with the most common lung cancer

Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain

Nivolumab extends survival for patients with the most common lung cancer ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )

Pembrolizumab shows promising activity against head and neck cancer

Dr Tanguy Seiwert - University of Chicago, Chicago, USA

Pembrolizumab shows promising activity against head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )

Prostate cancer and pharmacokinetics: Expert discussion

Prof Axel S. Merseburger and Prof Romano Danesi

Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )

Latest developments in prostate cancer

Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter...

Latest developments in prostate cancer ( Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter Iversen )

New approaches to diffuse large B-cell lymphoma

Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust...

New approaches to diffuse large B-cell lymphoma ( Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust, Southampton, UK )

Comment: Metastatic triple-negative breast cancer responds to immunotherapy

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

Comment: Metastatic triple-negative breast cancer responds to immunotherapy ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )

More from ecancer